Download PDF
Thromb Haemost 1975; 33(02): 221-225
DOI: 10.1055/s-0038-1647875
Original Article
Schattauer GmbH

Assay of Brinase Inhibitors with Soluble and Insoluble Substrates

D Nyman
1   Coagulation and Fibrinolysis Laboratory of the Dept. of Internal Medicine, University of Basle, Switzerland
,
F Duckert
1   Coagulation and Fibrinolysis Laboratory of the Dept. of Internal Medicine, University of Basle, Switzerland
› Author Affiliations
Further Information

Publication History

Received 21 August 1974

Accepted 15 December 1974

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

Summary

Two methods for the assay of brinase inhibitors are compared. Neither provided a reliable means of brinase dose prediction. Overdosage can, however, be avoided by preinfusion inhibitor assay.

 

  • References

  • 1 Amundsen E, Svendsen L, Vefling A. A sensitive photometric method for the determination of plasma inhibition towards plasmin and brinase. IVth International Congress on Thrombosis and Hemostasis; Vienna: Abstr. 1973: 54
    Google Scholar
  • 2 Bergkvist R. The proteolytic enzymes of Aspergillus oryzae IV On the inhibition of the enzymes by serum. Acta Chemica Scandinavica 1963; 17: 2239
    CrossrefPubMedGoogle Scholar
  • 3 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica 1957; 17: 235
    PubMedGoogle Scholar
  • 4 Fitzgerald D. E, Frisch E. P. Relief of chronic peripheral artery obstruction by intravenous brinase. Journal of the Irish Medical Association 1973; 66: 3
    PubMedGoogle Scholar
  • 5 Freedman H. J, Roschlau W. H. E. Some factors influencing the toxicity of thrombolytic enzymes (brinase). Canadian Journal of Physiology and Pharmacology 1970; 48: 69
    CrossrefPubMedGoogle Scholar
  • 6 Frisch E. P, Blombäck M, Ekeström D, Kiessling H, Lund F, Magaard F. Dosage of brinase based on determination of brinase inhibitors and coagulation studies in 17 patients treated with the enzyme. To be published 1975
    PubMedGoogle Scholar
  • 7 Kiessling H. Personal communications 1973
    PubMed
  • 8 Lund F, Ekeström S, Frisch E. P, Magaard F. Thrombolytic treatment with brinase of peripheral obliterative arterial disease with ischemic skin lesions. Lecture at the Annual Meeting of the Swedish Medical Association 1973: 29 November
    PubMedGoogle Scholar
  • 9 Nyman D, da Silva M. A, Widner L. K, Duckert F. Thrombolytische Behandlung arterieller Verschlüsse mit Brinase, einem proteolytischen Enzym aus Aspergillus. Schweizerische medizinische Wochenschrift 1974; 104: 1865
    PubMedGoogle Scholar
  • 10 Roschlau W. H. E. The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Canadian Journal of Physiology and Pharmacology 1964; 42: 109
    CrossrefPubMedGoogle Scholar
  • 11 Svaerd P. O, Bergkvist R. Unpublished results 1962
    PubMed
  • 12 Wissenschaftliche Tabellen 7. Edition J. R. Geigy A.G., Pharma, Basel 1968; 552
    PubMed